ABEONA THERAPEUTICS
Abeona Therapeutics is developing gene therapy-based potential cures for the deadly childhood diseases Sanfilippo (SF) Syndrome Type A and Type B. Its multi-platform expertise across the manufacture, delivery, development, and discovery of the novel gene and cell therapies has it uniquely positioned for success. Underpinning the Companyโs robust pipeline is its fully-operational manufacturing facility producing therapies and vectors for preclinical and clinical studies. Abeona is also developing the AIM Vector Platform: 100+ next-generation AAV capsids for delivering gene therapies targeting a wide range of organs and multiple routes of delivery.
ABEONA THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Manufacturing Medical Device
Founded:
1989-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.abeonatherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
(216)287-5408
Email Addresses:
[email protected]
Total Funding:
274.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2009-12-19 | RF Wireless Solutions | RF Wireless Solutions acquired by Abeona Therapeutics | N/A |
Investors List
Jefferies
Jefferies investment in Post-IPO Equity - Abeona Therapeutics
H. C. Wainwright & Co.
H. C. Wainwright & Co. investment in Post-IPO Equity - Abeona Therapeutics
Maxim Group
Maxim Group investment in Post-IPO Equity - Abeona Therapeutics
FBR & Co
FBR & Co investment in Post-IPO Equity - Abeona Therapeutics
RBC Capital Markets
RBC Capital Markets investment in Post-IPO Equity - Abeona Therapeutics
Cantor Fitzgerald
Cantor Fitzgerald investment in Post-IPO Equity - Abeona Therapeutics
Stop Sanfilippo
Stop Sanfilippo investment in Grant - Abeona Therapeutics
George Soros
George Soros investment in Post-IPO Equity - Abeona Therapeutics
Key Employee Changes
Official Site Inspections
http://www.abeonatherapeutics.com Semrush global rank: 4.71 M Semrush visits lastest month: 2.02 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149